Arcadia Biosciences, Inc.

NasdaqCM:RKDA Stock Report

Market Cap: US$2.9m

Arcadia Biosciences Past Earnings Performance

Past criteria checks 0/6

Arcadia Biosciences has been growing earnings at an average annual rate of 1.1%, while the Food industry saw earnings growing at 13.7% annually. Revenues have been growing at an average rate of 29% per year.

Key information

1.1%

Earnings growth rate

47.4%

EPS growth rate

Food Industry Growth16.0%
Revenue growth rate29.0%
Return on equity-103.6%
Net Margin-246.9%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

We're Hopeful That Arcadia Biosciences (NASDAQ:RKDA) Will Use Its Cash Wisely

Mar 01
We're Hopeful That Arcadia Biosciences (NASDAQ:RKDA) Will Use Its Cash Wisely

Arcadia Biosciences to raise $5M in securities offering

Aug 15

Arcadia Biosciences: Market Still Unconvinced Of Its Health Offerings

Nov 29

We Think Shareholders Should Be Aware Of Some Factors Beyond Arcadia Biosciences' (NASDAQ:RKDA) Profit

Nov 22
We Think Shareholders Should Be Aware Of Some Factors Beyond Arcadia Biosciences' (NASDAQ:RKDA) Profit

The Future Looks Bright For Arcadia Biosciences

Dec 01

Arcadia Biosciences EPS misses by $0.06

Nov 12

Revenue & Expenses Breakdown
Beta

How Arcadia Biosciences makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:RKDA Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 235-13150
30 Sep 237-18180
30 Jun 236-16170
31 Mar 238-20180
31 Dec 227-11150
30 Sep 229-17180
30 Jun 2210-17200
31 Mar 229-21220
31 Dec 217-15220
30 Sep 21124210
30 Jun 2110-1190
31 Mar 219-5170
31 Dec 208-5160
30 Sep 201-20150
30 Jun 201-28150
31 Mar 201-14140
31 Dec 191-29140
30 Sep 191-23130
30 Jun 191-5120
31 Mar 191-15120
31 Dec 181-13120
30 Sep 182-16110
30 Jun 183-25100
31 Mar 183-22100
31 Dec 174-16110
30 Sep 173-18110
30 Jun 174-18110
31 Mar 173-19110
31 Dec 163-20110
30 Sep 164-18120
30 Jun 165-18120
31 Mar 165-18120
31 Dec 155-21110
30 Sep 157-21110
30 Jun 157-25100
31 Mar 156-26110
31 Dec 147-22100
30 Sep 146-21100
30 Jun 147-16100
31 Mar 147-1380
31 Dec 136-1380

Quality Earnings: RKDA is currently unprofitable.

Growing Profit Margin: RKDA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RKDA is unprofitable, but has reduced losses over the past 5 years at a rate of 1.1% per year.

Accelerating Growth: Unable to compare RKDA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RKDA is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (6.2%).


Return on Equity

High ROE: RKDA has a negative Return on Equity (-103.64%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.